<Summary id="CDR0000811128" SVPC="Yes" SuppressOnThisPageSection="Yes"><SummaryMetaData><SummaryType>Treatment</SummaryType><SummaryAudience>Patients</SummaryAudience><SummaryLanguage>English</SummaryLanguage><SummaryDescription>Learn how bladder cancer is treated, based on the stage of the cancer.</SummaryDescription><SummaryURL xref="https://www.cancer.gov/types/bladder/treatment/by-stage">Treatment of Bladder Cancer by Stage</SummaryURL><MainTopics><TermRef ref="CDR0000038767">bladder cancer</TermRef></MainTopics><SummaryKeyWords><SummaryKeyWord>bladder cancer</SummaryKeyWord><SummaryKeyWord>bladder cancer treatment by stage</SummaryKeyWord></SummaryKeyWords></SummaryMetaData><SummaryTitle>Treatment of Bladder Cancer by Stage</SummaryTitle><AltTitle TitleType="Browser">Treatment of Bladder Cancer by Stage</AltTitle><AltTitle TitleType="CancerTypeHomePage">Treatment of Bladder Cancer by Stage</AltTitle><SummarySection id="_1"><SectMetaData><SectionType>Introductory Text</SectionType></SectMetaData><Para id="_2"><SummaryRef href="CDR0000811057" url="/types/bladder/stages">Bladder cancer stage and grade</SummaryRef> are important factors in deciding the best treatment for bladder cancer. Other factors, such as your preferences and overall health, are also important.</Para><Para id="_322">Palliative therapy aims to relieve symptoms and improve the quality of life for people with life-threatening diseases like cancer. It is helpful at all stages of cancer. Many cancer treatments can also be used as palliative therapy to enhance comfort. Learn more about <ExternalRef xref="https://www.cancer.gov/about-cancer/advanced-cancer/care-choices/palliative-care-fact-sheet">Palliative Care in Cancer</ExternalRef>.</Para><Para id="_321">For some people, taking part in a clinical trial of new cancer drugs or treatment combinations may be an option. To learn about clinical trials, including how to find and join one, visit <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">Clinical Trials Information for Patients and Caregivers</ExternalRef>. </Para></SummarySection><SummarySection id="_3"><Title>Treatment of stages 0 and I bladder cancer</Title><Para id="_323"><GlossaryTermRef href="CDR0000350363" dictionary="Cancer.gov" audience="Patient">Stage 0</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045122" dictionary="Cancer.gov" audience="Patient">stage I</GlossaryTermRef> bladder cancer, also known as non-muscle-invasive bladder cancer (NMIBC), haven't spread to the muscle layer of the bladder. Treatment of NMIBC depends on several factors: </Para><ItemizedList id="_324" Style="bullet"><ListItem>the risk level of the cancer (low, intermediate, or high) for <GlossaryTermRef href="CDR0000045861" dictionary="Cancer.gov" audience="Patient">recurrence</GlossaryTermRef> or becoming muscle-invasive</ListItem><ListItem>the <GlossaryTermRef href="CDR0000045885" dictionary="Cancer.gov" audience="Patient">stage</GlossaryTermRef> and <GlossaryTermRef href="CDR0000774694" dictionary="Cancer.gov" audience="Patient">grade</GlossaryTermRef> of the cancer</ListItem><ListItem>the size and number of tumors</ListItem></ItemizedList><Para id="_325">The first treatment is usually a surgical procedure called <GlossaryTermRef href="CDR0000045971" dictionary="Cancer.gov" audience="Patient">transurethral resection (TUR)</GlossaryTermRef> with <GlossaryTermRef href="CDR0000046393" dictionary="Cancer.gov" audience="Patient">fulguration</GlossaryTermRef> to remove the tumor. Sometimes, surgery might be repeated if the first doesn't remove enough of the tumor or does not include a sample from the muscle layer. If a repeat surgery finds that the cancer has invaded the muscle layer, it will be treated as muscle-invasive bladder cancer (stage II bladder cancer or higher). </Para><Para id="_326">Because stage 0 and stage I bladder cancer often come back after surgery, most people receive <GlossaryTermRef href="CDR0000811564" dictionary="Cancer.gov" audience="Patient">intravesical chemotherapy</GlossaryTermRef> with <DrugRef href="CDR0000712481" url="/about-cancer/treatment/drugs/mitomycin">mitomycin</DrugRef> or <DrugRef href="CDR0000495426" url="/about-cancer/treatment/drugs/gemcitabinehydrochloride">gemcitabine</DrugRef> or intravesical <GlossaryTermRef href="CDR0000045987" dictionary="Cancer.gov" audience="Patient">BCG</GlossaryTermRef> at the time of their first surgery. To help lower the risk of bladder cancer recurrence, your doctor may recommend you continue having intravesical BCG for up to 3 years, depending on the characteristics of the cancer. This is called maintenance therapy.</Para><Para id="_341">To learn more about the treatments below, visit <SummaryRef href="CDR0000811102" url="/types/bladder/treatment">Bladder Cancer Treatment</SummaryRef>.</Para><SummarySection id="_327"><Title>Treatment of low-risk bladder cancer</Title><Para id="_328">Low-risk bladder cancer might include small, single, <GlossaryTermRef href="CDR0000386213" dictionary="Cancer.gov" audience="Patient">low-grade</GlossaryTermRef> tumors. </Para><Para id="_329">Treatment typically includes TUR with fulguration and intravesical therapy given around the time of surgery, followed by surveillance. Surveillance means closely watching your condition but not giving any treatment unless the cancer returns.</Para></SummarySection><SummarySection id="_330"><Title>Treatment of intermediate-risk bladder cancer</Title><Para id="_331">Intermediate-risk bladder cancer might include multiple or large, slow-growing stage 0a tumors, slow-growing stage 0a tumors that recur within 1 year, a single fast-growing stage 0a tumor, or a slow-growing stage I tumor.</Para><Para id="_332">Treatment typically includes TUR with fulguration, followed by <GlossaryTermRef href="CDR0000046340" dictionary="Cancer.gov" audience="Patient">intravesical</GlossaryTermRef> therapy (BCG or chemotherapy with mitomycin or gemcitabine). Depending on the characteristics of the cancer, your doctor may recommend that you continue having intravesical BCG for up to 1 year to lower the risk of recurrence. Surveillance with regular cystoscopies (bladder inspections with a camera) and possibly additional imaging tests are used to monitor for signs of cancer recurrence or progression.</Para></SummarySection><SummarySection id="_333"><Title>Treatment of high-risk bladder cancer</Title><Para id="_334">High-risk bladder cancer might include multiple or large high-grade stage 0a tumors, the presence of carcinoma in situ (stage 0is), and fast-growing stage I tumors.</Para><Para id="_335">Treatment typically includes TUR with fulguration, followed by intravesical BCG therapy.  Sometimes, intravesical BCG is continued for up to 3 years to lower the risk of recurrence.  If you have multiple tumors or carcinoma in situ, a type of high-grade stage 0 cancer, another option is surgery to remove part or all of your bladder (cystoscopy).</Para></SummarySection><SummarySection id="_336"><Title>Treatment of very high-risk bladder cancer</Title><Para id="_337">Very high-risk bladder cancer might include cancer that does not respond to intravesical BCG, that recurs in the <GlossaryTermRef href="CDR0000046640" dictionary="Cancer.gov" audience="Patient">urethra</GlossaryTermRef>, or that involves cancer cells detected in the blood or <GlossaryTermRef href="CDR0000793442" dictionary="Cancer.gov" audience="Patient">lymph system</GlossaryTermRef> near the tumor. Very high-risk bladder cancer has a greater chance of progressing to muscle-invasive disease (stage II or higher).</Para><Para id="_338">If you have many tumors or carcinoma in situ (a type of high-grade stage 0 cancer), partial or complete cystectomy (surgical removal of the bladder) may be an option. If you have carcinoma in situ, cannot or choose not to have a cystectomy, and BCG did not work, other options include intravesical chemotherapy, the <GlossaryTermRef href="CDR0000045729" dictionary="Cancer.gov" audience="Patient">immunotherapy</GlossaryTermRef> drug <DrugRef href="CDR0000764622" url="/about-cancer/treatment/drugs/pembrolizumab">pembrolizumab</DrugRef> given through a vein, or intravesical immunotherapy with <DrugRef href="CDR0000811177" url="/about-cancer/treatment/drugs/nadofaragene-firadenovec-vncg">nadofaragene firadenovec-vncg</DrugRef> or <DrugRef href="CDR0000815439" url="/about-cancer/treatment/drugs/nogapendekin-alfa-inbakicept-pmln">nogapendekin alfa inbakicept-pmln</DrugRef>.</Para></SummarySection></SummarySection><SummarySection id="_14"><Title>Treatment of stages II and III bladder cancer</Title><Para id="_15">The two main treatments for <GlossaryTermRef href="CDR0000045123" dictionary="Cancer.gov" audience="Patient">stage II</GlossaryTermRef>  and <GlossaryTermRef href="CDR0000045124" dictionary="Cancer.gov" audience="Patient">stage III</GlossaryTermRef> bladder cancer   are radical cystectomy or a combination of   <GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">radiation therapy</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">chemotherapy</GlossaryTermRef>.</Para><Para id="_16">Radical cystectomy is surgery to remove the bladder and surrounding tissues and organs. Surgery to make a new way for urine to leave the body (called urinary diversion) will be done. Additional treatments may be given before or after surgery:</Para><ItemizedList id="_17" Style="bullet">
     <ListItem>Chemotherapy may be given before surgery to people who are well enough to tolerate it. Giving combination chemotherapy that includes <DrugRef href="CDR0000533338" url="/about-cancer/treatment/drugs/cisplatin">cisplatin</DrugRef>  before surgery has been shown to help people live longer than surgery alone.</ListItem><ListItem>The <GlossaryTermRef href="CDR0000045729" dictionary="Cancer.gov" audience="Patient">immunotherapy</GlossaryTermRef>  drug <DrugRef href="CDR0000767749" url="/about-cancer/treatment/drugs/nivolumab">nivolumab</DrugRef>  may be given if the cancer has a high risk of coming back after surgery or did not respond to chemotherapy.</ListItem></ItemizedList><Para id="_18">If you are unable or choose not to have surgery, treatment may include a combination of radiation therapy  and chemotherapy, such as cisplatin and <DrugRef href="CDR0000537894" url="/about-cancer/treatment/drugs/fluorouracil">fluorouracil</DrugRef>, given at the same time. Giving chemotherapy at the same time as radiation therapy helps the radiation therapy work better.</Para><Para id="_19">Partial cystectomy (removal of part of the bladder) is a less common treatment for stages II and III bladder cancer.</Para><Para id="_342">To learn more about these treatments, visit <SummaryRef href="CDR0000811102" url="/types/bladder/treatment">Bladder Cancer Treatment</SummaryRef>.</Para></SummarySection><SummarySection id="_22"><Title>Treatment of stage IV bladder cancer</Title><Para id="_339">Treatment for <GlossaryTermRef href="CDR0000045125" dictionary="Cancer.gov" audience="Patient">stage IV bladder cancer</GlossaryTermRef> depends on whether the cancer is <GlossaryTermRef href="CDR0000045955" dictionary="Cancer.gov" audience="Patient">locally advanced</GlossaryTermRef> or <GlossaryTermRef href="CDR0000044058" dictionary="Cancer.gov" audience="Patient">metastatic</GlossaryTermRef>. Treatment for metastatic bladder cancer is aimed at relieving symptoms and improving quality of life while also slowing the growth and spread of the cancer.</Para><Para id="_23">Treatment of stage IVA (locally advanced) bladder cancer   may include:</Para><ItemizedList id="_24" Style="bullet">
     <ListItem>the <GlossaryTermRef href="CDR0000045729" dictionary="Cancer.gov" audience="Patient">immunotherapy</GlossaryTermRef> drug <DrugRef href="CDR0000764622" url="/about-cancer/treatment/drugs/pembrolizumab">pembrolizumab</DrugRef> in combination with the <GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">targeted therapy</GlossaryTermRef> drug <DrugRef href="CDR0000800196" url="/about-cancer/treatment/drugs/enfortumabvedotin-ejfv">enfortumab vedotin</DrugRef></ListItem><ListItem>the immunotherapy drug <DrugRef href="CDR0000767749" url="/about-cancer/treatment/drugs/nivolumab">nivolumab</DrugRef> in combination with the <GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">chemotherapy</GlossaryTermRef> drugs <DrugRef href="CDR0000533338" url="/about-cancer/treatment/drugs/cisplatin">cisplatin</DrugRef> and <DrugRef href="CDR0000495426" url="/about-cancer/treatment/drugs/gemcitabinehydrochloride">gemcitabine</DrugRef></ListItem><ListItem>the chemotherapy drugs cisplatin and gemcitabine followed by the immunotherapy drug <DrugRef href="CDR0000787910" url="/about-cancer/treatment/drugs/avelumab">avelumab</DrugRef></ListItem><ListItem>for people well enough to tolerate it, cisplatin-based <GlossaryTermRef href="CDR0000301626" dictionary="Cancer.gov" audience="Patient">systemic chemotherapy</GlossaryTermRef>, such as one of the following regimens:<ItemizedList id="_25" Style="dash">
     <ListItem><GlossaryTermRef href="CDR0000322855" dictionary="Cancer.gov" audience="Patient">dose-dense</GlossaryTermRef> <DrugRef href="CDR0000793877" url="/about-cancer/treatment/drugs/MVAC">methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC)</DrugRef></ListItem><ListItem><DrugRef href="CDR0000533338" url="/about-cancer/treatment/drugs/cisplatin">cisplatin</DrugRef>, <DrugRef href="CDR0000586940" url="/about-cancer/treatment/drugs/methotrexate-sodium">methotrexate</DrugRef>, and <DrugRef href="CDR0000688288" url="/about-cancer/treatment/drugs/vinblastinesulfate">vinblastine</DrugRef> (CMV)</ListItem></ItemizedList></ListItem><ListItem>pembrolizumab alone</ListItem><ListItem>a cisplatin-based chemotherapy regimen  followed by surgery to remove the bladder and surrounding tissues and organs (radical cystectomy) and <GlossaryTermRef href="CDR0000446222" dictionary="Cancer.gov" audience="Patient">urinary diversion</GlossaryTermRef> or surgery alone</ListItem><ListItem><GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">radiation therapy</GlossaryTermRef>  and chemotherapy, such as cisplatin and <DrugRef href="CDR0000537894" url="/about-cancer/treatment/drugs/fluorouracil">fluorouracil</DrugRef>, given at the same time, to help the radiation therapy work better</ListItem><ListItem>urinary diversion, as <GlossaryTermRef href="CDR0000045815" dictionary="Cancer.gov" audience="Patient">palliative therapy</GlossaryTermRef>  or to prevent a blockage of urine that could cause kidney damage</ListItem><ListItem>surgery to remove part or all of the bladder (cystectomy) as palliative therapy</ListItem></ItemizedList><Para id="_26">Treatment of stage IVB (metastatic) bladder cancer  may include:</Para><ItemizedList id="_27" Style="bullet">
     <ListItem>the immunotherapy drug pembrolizumab in combination with the targeted therapy drug enfortumab vedotin</ListItem><ListItem>the immunotherapy drug nivolumab in combination with the chemotherapy drugs cisplatin and gemcitabine</ListItem><ListItem>the chemotherapy drugs cisplatin and gemcitabine followed by the immunotherapy drug avelumab</ListItem><ListItem>systemic  chemotherapy, such as one of the   following regimens:<ItemizedList id="_28" Style="dash">
     <ListItem>gemcitabine with either cisplatin or <DrugRef href="CDR0000557107" url="/about-cancer/treatment/drugs/carboplatin">carboplatin</DrugRef></ListItem><ListItem>dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC)</ListItem><ListItem>cisplatin, methotrexate, and vinblastine (CMV)</ListItem></ItemizedList></ListItem><ListItem>an immunotherapy  drug alone, such as avelumab, nivolumab, or pembrolizumab</ListItem><ListItem>radiation therapy as palliative therapy</ListItem><ListItem>urinary diversion, as palliative therapy or to prevent a blockage of urine that could damage the kidneys</ListItem><ListItem>surgery to remove part or all of the bladder (cystectomy) as palliative therapy</ListItem></ItemizedList><Para id="_300">To learn more about these treatments, visit <SummaryRef href="CDR0000811102" url="/types/bladder/treatment">Bladder Cancer Treatment</SummaryRef>.</Para></SummarySection><SummarySection id="_320"><Title>Treatment of recurrent bladder cancer</Title><Para id="_33">Treatment of bladder cancer that has recurred (come back) depends on previous treatment and where the cancer has come back. Treatment may include:</Para><ItemizedList id="_34" Style="bullet">
     <ListItem><GlossaryTermRef href="CDR0000301626" dictionary="Cancer.gov" audience="Patient">systemic  chemotherapy</GlossaryTermRef>, such one of the following regimens:<ItemizedList id="_35" Style="bullet">
     <ListItem><DrugRef href="CDR0000495426" url="/about-cancer/treatment/drugs/gemcitabinehydrochloride">gemcitabine</DrugRef> with either <DrugRef href="CDR0000533338" url="/about-cancer/treatment/drugs/cisplatin">cisplatin</DrugRef> or <DrugRef href="CDR0000557107" url="/about-cancer/treatment/drugs/carboplatin">carboplatin</DrugRef></ListItem><ListItem><GlossaryTermRef href="CDR0000322855" dictionary="Cancer.gov" audience="Patient">dose-dense</GlossaryTermRef> <DrugRef href="CDR0000793877" url="/about-cancer/treatment/drugs/MVAC">methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC)</DrugRef></ListItem><ListItem>cisplatin, <DrugRef href="CDR0000586940" url="/about-cancer/treatment/drugs/methotrexate-sodium">methotrexate</DrugRef>, and <DrugRef href="CDR0000688288" url="/about-cancer/treatment/drugs/vinblastinesulfate">vinblastine</DrugRef></ListItem></ItemizedList></ListItem><ListItem>an <GlossaryTermRef href="CDR0000045729" dictionary="Cancer.gov" audience="Patient">immunotherapy</GlossaryTermRef>  drug, such as <DrugRef href="CDR0000787910" url="/about-cancer/treatment/drugs/avelumab">avelumab</DrugRef>, <DrugRef href="CDR0000767749" url="/about-cancer/treatment/drugs/nivolumab">nivolumab</DrugRef>, or <DrugRef href="CDR0000764622" url="/about-cancer/treatment/drugs/pembrolizumab">pembrolizumab</DrugRef> </ListItem><ListItem>a <GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">targeted therapy</GlossaryTermRef> drug, such as <DrugRef href="CDR0000800196" url="/about-cancer/treatment/drugs/enfortumabvedotin-ejfv">enfortumab vedotin</DrugRef>, <DrugRef href="CDR0000797598" url="/about-cancer/treatment/drugs/erdafitinib">erdafitinib</DrugRef>, or <DrugRef href="CDR0000760376" url="/about-cancer/treatment/drugs/ramucirumab">ramucirumab</DrugRef></ListItem><ListItem>surgery for non-muscle-invasive or <GlossaryTermRef href="CDR0000045754" dictionary="Cancer.gov" audience="Patient">localized</GlossaryTermRef> tumors, which may be followed by immunotherapy and chemotherapy</ListItem><ListItem><GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">radiation therapy</GlossaryTermRef>  as palliative therapy</ListItem></ItemizedList><Para id="_37">To learn more about these treatments, visit <SummaryRef href="CDR0000811102" url="/types/bladder/treatment">Bladder Cancer Treatment</SummaryRef>.</Para></SummarySection><DateFirstPublished>2023-02-16</DateFirstPublished><DateLastModified>2024-09-12</DateLastModified></Summary>
